Bg pattern

MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Meropenem Steriscience 500 mg powder for injectable and infusion solution EFG

Meropenem Steriscience 1000 mg powder for injectable and infusion solution EFG

Meropenem

Read the entire leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor, pharmacist, or nurse.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What is Meropenem Steriscience and what is it used for
  2. What you need to know before starting to use Meropenem Steriscience
  3. How to use Meropenem Steriscience
  4. Possible side effects
  5. Storage of Meropenem Steriscience
  6. Package contents and additional information

1. What is Meropenem Steriscience and what is it used for

Meropenem Steriscience contains the active ingredient meropenem and belongs to a group of medications called carbapenem antibiotics. It works by destroying bacteria that can cause severe infections.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or common cold.

It is essential to follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medications down the drain or in the trash.

Meropenem is used to treat the following infections in adults and children over 3 months of age:

  • Infection affecting the lungs (pneumonia)
  • Bronchial and lung infections in patients with cystic fibrosis
  • Complicated urinary tract infections
  • Complicated abdominal infections
  • Infections that can be acquired during and after childbirth
  • Complicated skin and soft tissue infections
  • Acute bacterial infection of the brain (meningitis)

Meropenem may be used to treat patients with neutropenia who present with fever suspected to be due to a bacterial infection.

Meropenem can be used to treat bacterial infections of the blood that may be associated with one of the aforementioned infections.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Meropenem Steriscience

Do not use Meropenem Steriscience:

  • if you are allergic to meropenem or any of the other components of this medication (listed in section 6);
  • if you are allergic (hypersensitive) to other antibiotics, such as penicillins, cephalosporins, or carbapenems, as you may also be allergic to meropenem.

Warnings and precautions

Consult your doctor or nurse before starting to use this medication if:

  • you have health problems, such as liver or kidney problems;
  • you have had severe diarrhea after taking other antibiotics.

You may test positive for a test (Coombs test) that indicates the presence of antibodies that can destroy red blood cells. Your doctor will discuss this with you.

You may experience signs and symptoms of severe skin reactions (see section 4). If this occurs, inform your doctor or nurse immediately so that they can treat the symptoms.

If you are unsure whether you are in any of these situations, consult your doctor or nurse before using this medication.

Children

This medication is not recommended for use in children under 3 months of age, as the safety and efficacy of meropenem have not been established in children of these ages.

Other medications and Meropenem SteriscienceInform your doctor, pharmacist, or nurse if you are using, have recently used, or may need to use any other medication.

This is because meropenem may affect the way some medications work, and some of these may have an effect on meropenem.

In particular, inform your doctor, pharmacist, or nurse if you are taking any of the following medications:

  • Probenecid (used to treat gout).
  • Valproic acid/sodium valproate/valpromide (used to treat epilepsy). Meropenem should not be used, as it may decrease the effect of sodium valproate.
  • Oral anticoagulant (used to treat or prevent blood clots).

Pregnancy and breastfeeding

Pregnancy

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. It is preferable to avoid using meropenem during pregnancy. Your doctor will decide whether you should use meropenem.

Breastfeeding

It is essential that, before receiving treatment with meropenem, you inform your doctor if you are breastfeeding or plan to breastfeed. A small amount of this medication may pass into breast milk. Therefore, your doctor will decide whether you should use meropenem during breastfeeding.

Driving and using machines

No studies have been conducted on the effects on the ability to drive and use machines.

This medication has been associated with headache and tingling or numbness in the skin (paresthesia). Either of these side effects could affect your ability to drive or use machines.

This medication may cause involuntary muscle movements, which can cause the body to shake rapidly and uncontrollably (convulsions). This is usually accompanied by a loss of consciousness. Do not drive or use machines if you experience this side effect.

Meropenem Steriscience contains sodium

Meropenem Steriscience 500 mg: This medication contains 45 mg of sodium (main component of table salt/cooking salt) per 500 mg dose. This is equivalent to 2.25% of the maximum daily recommended sodium intake for an adult.

Meropenem Steriscience 1000 mg: This medication contains 90 mg of sodium (main component of table salt/cooking salt) per 1000 mg dose. This is equivalent to 4.5% of the maximum daily recommended sodium intake for an adult.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to use Meropenem Steriscience

Follow your doctor's, pharmacist's, or nurse's instructions for administering this medication exactly. If you have any doubts, consult your doctor, pharmacist, or nurse again.

Use in adults

  • The dose depends on the type of infection you have, the area of the body where it is located, and its severity. Your doctor will decide what dose you need.
  • The normal dose in adults is between 500 mg (milligrams) and 2000 mg (milligrams). You will usually be given a dose every 8 hours. However, if your kidneys do not function well, you may receive the dose less frequently.

Use in children and adolescents

  • The dose for children over 3 months and up to 12 years is determined using the child's age and weight. The normal dose is between 10 mg and 40 mg of meropenem per kilogram (kg) of the child's weight. You will usually be given a dose every 8 hours. Children who weigh over 50 kg will be given an adult dose.

How to use Meropenem Steriscience

  • Meropenem will be administered to you as an injection or infusion into a large vein.
  • Meropenem will usually be administered by your doctor or nurse.
  • However, some patients, parents, or caregivers receive training to administer meropenem at home. The instructions for this are found in this leaflet (in the section called "Instructions for administering meropenem to yourself or to another person at home"). Follow your doctor's instructions for administering meropenem exactly. Consult your doctor if you have any doubts.
  • The injection should not be mixed with solutions containing other medications, nor should other medications be added to it.
  • The injection may take approximately 5 minutes or between 15 and 30 minutes. Your doctor will tell you how meropenem is administered.
  • Injections should usually be administered at the same time every day.

If you use more Meropenem Steriscience than you should

If you accidentally use more than the prescribed dose, contact your doctor or go to the nearest hospital immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to use Meropenem Steriscience

If you forget an injection, you should receive it as soon as possible. However, if it is almost time for your next injection, do not receive the missed one. Do not use a double dose (two injections at the same time) to make up for missed doses.

If you interrupt treatment with Meropenem Steriscience

Do not interrupt meropenem until your doctor tells you to do so.

If you have any other questions about using this medication, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Severe allergic reactions

If you experience any of the following signs and symptoms, inform your doctor or nurse immediately.You may need urgent medical treatment. The signs and symptoms may include a sudden onset of:

  • Severe rash, itching, or hives on the skin.
  • Swelling of the face, lips, tongue, or other parts of the body.
  • Shortness of breath, wheezing, or difficulty breathing.
  • Severe skin reactions, including:
    • Severe hypersensitivity reactions with fever, rash, and changes in blood test results showing liver activity (increased liver enzyme levels), increased eosinophils, and swollen lymph nodes. These may be signs of a multi-organ sensitivity disorder known as DRESS syndrome.
    • Severe scaly red rash, pus-filled bumps on the skin, blisters, or peeling skin, which may be accompanied by high fever and joint pain.
    • Severe skin reactions that may appear as circular red patches — often with central blisters — on the torso, peeling skin, or ulcers in the mouth, throat, nose, genitals, and eyes, which may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome) or a more severe form (toxic epidermal necrolysis).

Damage to red blood cells (frequency not known)

Symptoms include:

  • Shortness of breath when you do not expect it.
  • Red or brown urine.

If you observe any of the above, see a doctor immediately.

Other possible side effects:

Common (may affect up to 1 in 10 people)

  • Abdominal pain (stomach pain).
  • Nausea.
  • Vomiting.
  • Diarrhea.
  • Headache.
  • Rash, itching on the skin.
  • Pain and inflammation.
  • Increased platelet count in the blood (detected in a blood test).
  • Changes in blood tests, including those that show liver activity.

Uncommon (may affect up to 1 in 100 people)

  • Changes in blood, including a decrease in platelet count (which can make you bruise more easily), increased white blood cells, decreased white blood cells, and increased bilirubin. Your doctor may perform periodic blood tests.
  • Changes in blood tests, including those that show kidney activity.
  • Tingling sensation (paresthesia).
  • Mouth or vaginal infections caused by a fungus (thrush).
  • Inflammation of the intestine with diarrhea.
  • Pain in the veins where meropenem is injected.
  • Other changes in blood. Symptoms include frequent infections, fever, and sore throat. Your doctor may perform periodic blood tests.

Rare (may affect up to 1 in 1,000 people)

  • Seizures (convulsions).
  • Sudden confusion and disorientation (delirium).

Reporting side effects

It is essential to report suspected adverse reactions to the medication after its authorization. This allows for continuous monitoring of the benefit-risk ratio of the medication. Healthcare professionals are encouraged to report suspected adverse reactions through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaRAM.es.

5. Storage of Meropenem Steriscience

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date shown on the packaging and on the label of the vials after EXP. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Injection

After reconstitution:

Reconstituted solutions for intravenous use should be used immediately.

Chemical and physical stability in use has been demonstrated for the prepared solutions for intravenous injection for the following periods:

  • 3 hours at a maximum of 25 °C;
  • 6 hours under refrigeration conditions (2 °C to 8 °C).

Infusion

After reconstitution:

Reconstituted solutions for intravenous use should be used immediately.

When meropenem is dissolved in 0.9% sodium chloride (9 mg/ml), chemical and physical stability in use has been demonstrated for the prepared solutions for infusion for the following periods:

  • 3 hours stored at a maximum of 25 °C;
  • 24 hours stored under refrigeration conditions (2 °C to 8 °C).

When meropenem is dissolved in 5% glucose (dextrose) (50 mg/ml), the solution should be used immediately.

From a microbiological point of view, unless the reconstitution method rules out the risk of microbiological contamination, the product should be used immediately.

If not used immediately, the storage times and conditions are the responsibility of the user.

Do not freeze the reconstituted solution.

Medications should not be thrown down the drain or in the trash. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Contents of the pack and additional information

Composition of Meropenem Steriscience

The active substance is meropenem.

Each vial contains meropenem trihydrate equivalent to 500 mg or 1000 mg of meropenem.

The other component is sodium carbonate.

Appearance and pack contents of the product

Meropenem Steriscience is a white to pale yellow powder for solution for injection and infusion in a vial.

Meropenem Steriscience 500 mg powder for solution for injection and infusion

Transparent glass vial with a bromobutyl rubber stopper sealed with an easy-to-open aluminum cap and sky blue in color.

Meropenem Steriscience 1000 mg powder for solution for injection and infusion

Transparent glass vial with a bromobutyl rubber stopper sealed with an easy-to-open aluminum cap and red in color.

The product is available in pack sizes of 1 or 10 vials. Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Steriscience B.V.

Kranenburgweg 135-A

2583 ER The Hague

Netherlands

Manufacturer

Pharma Pack Hungary Kft.

H-2040, Budaörs, Vasút út 13

Hungary

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Belgium

Meropenem Steriscience 500 mg powder for solution for injection/infusion

Meropenem Steriscience 1000 mg powder for solution for injection/infusion

Bulgaria

Meropenem 500 mg ????? ?? ???????????/?????????? ???????

Meropenem 1000 mg ????? ?? ???????????/?????????? ???????

Estonia

Meropenem Steriscience

Finland

Meropenem Steriscience 500 mg injektio-/infuusiokuiva-aine liuosta varten

Meropenem Steriscience 1000 mg injektio-/infuusiokuiva-aine liuosta varten

France

Meropenem Steriscience 500 mg poudre pour solution injectable/pour perfusion

Meropenem Steriscience 1000 mg poudre pour solution injectable/pour perfusion

Netherlands

Meropenem Steriscience 500mg, poeder voor oplossing voor injectie of infusie

Meropenem Steriscience 1000 mg, poeder voor oplossing voor injectie of infusie

Croatia

Meropenem Steriscience 500 mg prašak za otopinu za injekciju/infuziju

Meropenem Steriscience 1000 mg prašak za otopinu za injekciju/infuziju

Ireland

Meropenem 500 mg powder for solution for injection/infusion

Meropenem 1000 mg powder for solution for injection/infusion

Italy

Meropenem Steriscience

Iceland

Meropenem 500 mg stungulyfs-/innrennslisstofn, lausn

Meropenem 1000 mg stungulyfs-/innrennslisstofn, lausn

Czech Republic

Meropenem Steriscience

Lithuania

Meropenem 500 mg milteliai injekciniam ar infuziniam tirpalui

Meropenem 1000 mg milteliai injekciniam ar infuziniam tirpalui

Latvia

Meropenem Steriscience, 500 mg pulveris injekciju/infuziju škiduma pagatavošanai

Meropenem Steriscience, 1000 mg pulveris injekciju/infuziju škiduma pagatavošanai

Luxembourg

Meropenem 500 mg Pulver fir Léisung fir Injektioun / Infusioun

Meropenem 1000 mg Pulver fir Léisung fir Injektioun / Infusioun

Hungary

Meropenem Steriscience, 500 mg por oldatos injekcióhoz vagy infúzióhoz

Meropenem Steriscience, 1000 mg por oldatos injekcióhoz vagy infúzióhoz

Malta

Meropenem Steriscience 500 mg powder for solution for injection/infusion

Meropenem Steriscience 1000 mg powder for solution for injection/infusion

Norway

Meropenem Steriscience

Poland

Meropenem Steriscience

Portugal

Meropenem 500 mg pó para solução injetável/perfusão

Meropenem 1000 mg pó para solução injetável/perfusão

Austria

Meropenem Steriscience 500 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung

Meropenem Steriscience 1000 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung

Romania

Meropenem Steriscience 500 mg pulbere pentru solutie injectabila/ perfuzabila

Meropenem Steriscience 1000 mg pulbere pentru solutie injectabila/ perfuzabila

Greece

Meropenem 500 mg κ?νις για εν?σιμο δι?λυμα / ?γχυση

Meropenem 1000 mg κ?νις για εν?σιμο δι?λυμα / ?γχυση

Cyprus

Meropenem 500 mg Κ?νις για εν?σιμο δι?λυμα/ δι?λυμα προς ?γχυση

Meropenem 1000 mg Κ?νις για εν?σιμο δι?λυμα/ δι?λυμα προς ?γχυση

Slovak Republic

Meropenem Steriscience 500 mg prášok na injekcný/ infúzny roztok

Meropenem Steriscience 1000 mg prášok na injekcný/ infúzny roztok

Denmark

Meropenem Steriscience

Slovenia

Meropenem Steriscience 500 mg prašek za raztopino za injiciranje/infundiranje

Meropenem Steriscience 1000 mg prašek za raztopino za injiciranje/infundiranje

Spain

Meropenem Steriscience 500 mg polvo para solución inyectable y para perfusión

Meropenem Steriscience 1000 mg polvo para solución inyectable y para perfusión

Sweden

Meropenem Steriscience, 500 mg pulver till injektions-/infusionsvätska, lösning

Meropenem Steriscience, 1000 mg pulver till injektions-/infusionsvätska, lösning

Date of last revision of this leaflet:01 2022

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)

http://www.aemps.gob.es/.

Text on the correct use of antibiotics and prevention of bacterial resistance with numbered tips

This information is intended solely for healthcare professionals:

To consult all the information on administration guidelines, warnings, and precautions, instructions for reconstitution of the medicinal product before administration, etc., see the summary of product characteristics.

Instructions for administering meropenem to yourself or to another person at home

Some patients, parents, and caregivers are trained to administer meropenem at home.

Warning: This medicinal product should only be administered to yourself or to another person at home after a doctor or nurse has trained you.

How to prepare this medicinal product

  • The medicinal product must be mixed with another liquid (the diluent). Your doctor will tell you what amount of diluent to use.
  • Use the medicinal product immediately after preparation. Do not freeze it.
  1. Wash your hands and dry them very well. Prepare a clean work area.
  2. Remove the meropenem vial from the packaging. Check the vial and expiration date. Check that the vial is intact and has not been damaged.
  3. Remove the colored cap and clean the gray rubber stopper with a cotton swab soaked in alcohol. Let the rubber stopper dry.
  4. Insert a new sterile needle into a new sterile syringe, without touching the ends.
  5. Draw up the recommended amount of sterile "water for injections" with the syringe. The amount of liquid you need is shown in the table below:

Meropenem dose

Amount of "water for injections" needed for dilution

500 mg (milligrams)

10 ml (milliliters)

1000 mg

20 ml

1500 mg

30 ml

2000 mg

40 ml

Note:If the amount of meropenem prescribed for you is more than 1 g, you will need to use more than one meropenem vial. You can then draw up the liquid from the vials into a syringe.

  1. Pierce the center of the gray rubber stopper with the syringe needle and inject the recommended amount of "water for injections" into the meropenem vial(s).
  2. Remove the needle from the vial and shake it well for about 5 seconds, or until all the powder has dissolved. Clean the gray rubber stopper again with a new cotton swab soaked in alcohol and let it dry. Before administration, the solution must be visually inspected for particles or color change. Use the solution only if it is transparent, colorless, or yellowish and does not contain particles.
  3. With the syringe plunger fully pushed into the syringe, pierce the gray rubber stopper again with the needle. You must then hold the syringe and vial and turn the vial upside down.
  4. Keeping the needle end in the liquid, pull the plunger and draw up all the liquid from the vial into the syringe.
  5. Remove the needle and syringe from the vial and discard the empty vial in an appropriate container.
  6. Hold the syringe vertically, with the needle facing up. Gently tap the syringe to make any bubbles in the liquid rise to the top of the syringe.
  7. Remove the air from the syringe by gently pushing the plunger until all the air has been removed.
  8. If you are using meropenem at home, dispose of the needles and infusion lines you have used properly. If your doctor decides to interrupt your treatment, dispose of any unused meropenem properly.

Administration of the injection

You can administer this medicinal product through a peripheral intravenous catheter or through a central port or line.

Administration of meropenem through a peripheral intravenous catheter

  1. Remove the needle from the syringe and carefully discard it in authorized containers for sharp objects.
  2. Clean the end of the peripheral intravenous catheter with a cotton swab soaked in alcohol and let it dry. Open the cannula cap and connect the syringe.
  3. Slowly press the syringe plunger to administer the antibiotic constantly over about 5 minutes.
  4. Once you have finished administering the antibiotic and the syringe is empty, remove it and flush the line as your doctor or nurse has recommended.
  5. Close the cannula cap and carefully discard the syringe in authorized containers for sharp objects.

Administration of meropenem through a central port or line

  1. Remove the cap from the port or line, clean the end of the line with a cotton swab soaked in alcohol, and let it dry.
  2. Connect the syringe and slowly press the plunger to administer the antibiotic constantly over about 5 minutes.
  3. Once you have finished administering the antibiotic, remove the syringe and flush the line as your doctor or nurse has recommended.
  4. Place a new clean cap on the central line and carefully discard the syringe in authorized containers for sharp objects.

Each vial is for single use.

The solution must be shaken before use. Before administration, it must be visually inspected for particles or color change. Use the solution only if it is transparent, colorless, or yellowish and does not contain particles.

For the storage conditions after reconstitution/dilution of the medicinal product, see section 5.

The disposal of unused medicinal product and all materials that have come into contact with it will be carried out in accordance with local regulations.

Online doctors for MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION

Discuss questions about MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
The active ingredient in MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION is meropenem. This information helps identify medicines with the same composition but different brand names.
Who manufactures MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION is manufactured by Steriscience B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MEROPENEM STERISCIENCE 1000 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION?
Other medicines with the same active substance (meropenem) include ARCHIFAR 1G POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, ARCHIFAR 500 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, MEROPENEM ACCORDPHARMA 1 g POWDER FOR INJECTION AND INFUSION SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media